Sling Therapeutics Announces Appointment of Jeffrey Kent, M.D., FACG, FACP, as Chief Medical Officer
– Dr. Kent brings greater than two decades of global industry experience to leadership team – – Appointment supports the global Phase 2b LIDS clinical trial for thyroid eye disease (TED) – Ann Arbor, MI, January 25, 2023 — Sling…